Clinical characteristics of idiopathic pulmonary fibrosis patients with diabetes mellitus: The national survey in Korea from 2003 to 2007

Journal of Korean Medical Science

Volumn 27, Issue 7, 2012, Pages 756-760

  Kim, Yu Jin ^a   Park, Jeong Woong ^a   Kyung, Sun Young ^a   Lee, Sang Pyo ^a   Chung, Man Pyo ^b   Kim, Young Hwan ^c   Lee, Jae Ho ^c   Kim, Yong Chul ^d   Ryu, Jong Seon ^e   Lee, Hong Lyeol ^e   Park, Choon Sik ^f   Uh, Soo Tak ^f   Lee, Young Chul ^g   Kim, Kwan Hyung ^h   Chun, Young Joon ⁱ   Park, Young Bum ^j   Kim, Dong Soon ^k   Jegal, Yongjin ^l   Lee, Jin Hwa ^m   Park, Moo Suk ⁿ   Jeong, Sung Hwan ^a   more..

^a Gachon University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Seoul National University Hospital   (South Korea)

^d Chonnam National University Medical School   (South Korea)

^e Inha University Hospital   (South Korea)

^f Soonchunhyang University College of Medicine   (South Korea)

^g Chonbuk National University Medical School   (South Korea)

^h The Catholic University of Korea College of Medicine   (South Korea)

ⁱ Keimyung University School of Medicine   (South Korea)

^j Hallym University College of Medicine   (South Korea)

^k University of Ulsan College of Medicine   (South Korea)

^l University of Ulsan College of Medicine   (South Korea)

^m Ewha Womans University School of Medicine   (South Korea)

ⁿ Yonsei University College of Medicine   (South Korea)

more..

Author keywords

Diabetes mellitus; High resolution computed tomography; Idiopathic pulmonary fibrosis

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FIBROSING ALVEOLITIS; HUMAN; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; RADIOGRAPHY; REGISTER; RETROSPECTIVE STUDY; SOUTH KOREA;

AGED; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; IDIOPATHIC PULMONARY FIBROSIS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; REGISTRIES; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84866492961     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2012.27.7.756     Document Type: Article

References (28)

1. Selman M, King TE, Pardo A; American Thorac Society; European Respiratory Society; American College of Chest Physicians. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001; 134: 136-51.
2. Park SW, Ahn MH, Jang HK, Jang AS, Kim DJ, Koh ES, Park JS, Uh ST, Kim YH, Park JS, et al. Interleukin-13 and its receptors in idiopathic interstitial pneumonia: clinical implications for lung function. J Korean Med Sci 2009; 24: 614-20.
3. Olson AL, Swigris JJ, Lezotte DC, Norris JM, Wilson CG, Brown KK. Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. Am J Respir Crit Care Med 2007; 176: 277-84.
4. Quadrelli S, Molinari L, Ciallella L, Spina JC, Sobrino E, Chertcoff J. Radiological versus histopathological diagnosis of usual interstitial pneumonia in the clinical practice: dose it have any survival difference? Respiration 2010; 79: 32-7.
5. Scott J, Johnston I, Britton J. What causes cryptogenic fibrosing alveolitis? A study of environmental exposure to dust. BMJ 1990; 301: 1015-7.
6. Hubbard R, Lewis S, Richards K, Johnston I, Britton J. Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis. Lancet 1996; 347: 284-9.
7. Enomoto T, Usuki J, Azuma A, Nakagawa T, Kudoh S. Diabetes mellitus may increased risk for idiopathic fibrosis. Chest 2003; 123: 2007-11.
8. Fernández Pérez ER, Daniels CE, Schroeder DR, St Sauver J, Hartman TE, Bartholmai BJ, Yi ES, Ryu JH. Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study. Chest 2010; 137: 129-37.
9. Garcia-Sancho Figueroa MC, Carrillo G, Pérez-Padilla R, Ferández-Plata MR, Buendia-Roldán I, Vargas HM, Selman M. Risk factors for idiopathic pulmonary fibrosis in a Mexican population. A case-control study. Respir Med 2010; 104: 305-9.
10. Gribbin J, Hubbard R, Smith C. Role of diabetes mellitus and gastrooesophageal reflux in the aetiology of idiopathic pulmonary fibrosis. Respir Med 2009; 103: 927-31.
11. Kim YJ, Park JW, Kyung SY, An CH, Lee SP, Chung MP, Park HY, Jeong SH. Association of diabetes mellitus and metabolic syndrome with idiopathic pulmonary fibrosis. Tuberc Respir Dis 2009; 67: 113-20.
12. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788-824.
13. American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonia. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002; 165: 277-304.
14. Miyake Y, Sasaki S, Yokoyama T, Chida K, Azuma A, Suda T, Kudoh S, Sakamoto N, Okamoto K, Kobashi G, et al. Case-control study of medical history and idiopathic pulmonary fibrosis in Japan. Respirology 2005; 10: 504-9.
15. Souza CA, Müller NL, Flint J, Wright JL, Churg A. Idiopathic pulmonary fibrosis: spectrum of high-resolution CT findings. AJR Am J Roentgenol 2005; 185: 1531-9.
16. Klein OL, Krishnan JA, Glick S, Smith LJ. Systemic review of the association between lung function and type 2 diabetes mellitus. Diabet Med 2010; 27: 977-87.
17. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999; 48: 1-9.
18. Kuwano K, Nakashima N, Inoshima I, Hagimoto N, Fujita M, Yoshimi M, Maeyama T, Hamada N, Watanabe K, Hara N. Oxidative stress in lung epithelial cells from patients with idiopathic interstitial pneumonia. Eur Respir J 2003; 21: 232-40.
19. Maritim AC, Sanders RA, Watkins JB 3rd. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003; 17: 24-38.
20. Rhyu DY, Yang Y, Ha H, Lee GT, Song JS, Uh ST, Lee HB. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol 2005; 16: 667-75.
21. Kinnula VL, Fattman CL, Tan RJ, Oury TD. Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy. Am J Respir Crit Care Med 2005; 172: 417-22.
22. Teramoto S, Fukuchi Y, Uejima Y, Shu CY, Orimo H. Superoxide anion formation and glutathione metabolism of blood in patients with idiopathic pulmonary fibrosis. Biochem Mol Med 1995; 55: 66-70.
23. Yu T, Robotham JL, Yoon Y. Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc Natl Acad Sci U S A 2006; 103: 2653-8.
24. Panos RJ, Mortenson RL, Niccoli SA, King TE Jr. Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment. Am J Med 1990; 88: 396-404.
25. Kizer JR, Zisman DA, Blumenthal NP, Kotloff RM, Kimmel SE, Strieter RM, Arcasoy SM, Ferrari VA, Hansen-Flaschen J. Association between pulmonary fibrosis and coronary artery disease. Arch Intern Med 2004; 164: 551-6.
26. Nathan SD, Basavaraj A, Reichner C, Shlobin OA, Ahmad S, Kiernan J, Burton N, Barnett SD. Prevealence and impact of coronary artery disease in idiopathic pulmonary fibrosis. Respir Med 2010; 104: 1035-41.
27. Hubbard RB, Smith C, Le Jeune I, Gribbin J, Fogarty AW. The association between idiopathic pulmonary fibrosis and vascular disease: a population-based study. Am J Respir Crit Care Med 2008; 178: 1257-61.
28. Matsushita H, Tanaka S, Saiki Y, Hara M, Nakata K, Tanimura S, Banba J. Lung cancer associated with usual interstitial pneumonia. Pathol Int 1995; 45: 925-32.